Executive Summary: Key Legal and Evidentiary Issues

• Plaintiff sought to amend his civil claim to include allegations of lack of informed consent related to his admission to a rehab facility.

• Physician defendants objected, arguing the new claims were materially different and potentially barred by limitation periods.

• Allegations include misdiagnosis, coercive admission tactics, and failure to explain treatment risks and alternatives.

• Plaintiff claimed exemption or postponement of limitation periods due to psychological trauma and disability (PTSD and depression).

• Court found informed consent claims closely connected to existing negligence allegations and allowed the amendment.

• Leave to amend was granted with costs in the cause, but without prejudice to defendants raising limitation defences at trial.

Facts and outcome of the case

Background and context of the dispute

John Doe, a U.S. resident, was admitted to Edgewood Holdings (2013) Ltd.’s private addiction rehabilitation facility in Nanaimo, British Columbia in October 2016. The admission followed an intervention organized by his spouse, and his 58-day stay cost $28,000, paid by his parents. Doe alleges that he was admitted without an independent diagnosis by qualified medical personnel and that the decision to admit him was based on flawed assessments by the facility's medical staff—Dr. Gary Richardson and Dr. Mel Vincent.

He claims that the doctors misdiagnosed him with alcohol use disorder and a “gaming addiction,” and that his admission was involuntary, coerced through psychological pressure, false statements, and seizure of personal belongings. Additionally, he alleges that he was sexually assaulted by his assigned roommate, J.B., during his stay, and that the facility and doctors are liable due to their negligence.

Procedural history and application to amend pleadings

The plaintiff initially filed his civil claim in December 2020, and over time, filed several amended versions. He later sought to add new allegations of lack of informed consent, claiming that he was not adequately informed of the diagnosis, risks, or alternative treatment options before being admitted. These proposed amendments were opposed by the physician defendants, who argued that they introduced a new and distinct cause of action that might be time-barred under British Columbia’s Limitation Act.

The plaintiff countered by arguing that the new claims merely clarified existing negligence allegations and were based on the same factual matrix. He also argued for postponement or exemption from limitation rules due to the psychological impact of the alleged sexual assaults and diagnoses of PTSD and depression.

Court’s reasoning and decision

The court agreed that the informed consent allegations introduced a new angle but found them sufficiently related to existing claims to allow amendment. It accepted that there was at least a basic connection between the new and existing allegations, especially since the existing pleadings already touched on misdiagnosis and coercion. The judge found that questions about limitation periods—whether they had expired or could be postponed—were best resolved at trial, especially given the plaintiff's claim that he was under a legal “disability” due to trauma.

Despite a notable delay in bringing forward the amendment, much of which was attributed to the plaintiff’s counsel’s oversight, the court accepted the explanation as an honest, if mistaken, judgment. It did not find that allowing the amendment would unduly prejudice the defendants, particularly with over a year remaining before trial.

Outcome

The plaintiff was granted leave to file the third amended notice of civil claim, which includes the new informed consent allegations. This decision was made without prejudice to the defendants' right to raise a limitation defence at trial. The plaintiff was awarded costs of the application, to be paid by the physician defendants, but only “in the cause,” meaning it is contingent on the plaintiff ultimately prevailing in the case. No damages were awarded at this stage, as the decision was procedural. The trial is scheduled for July 2026.